# Therapy of Complicated Intra-Abdominal Infections With Moxifloxacin or Ertapenem

> **NCT00492726** · PHASE3 · COMPLETED · sponsor: **Bayer** · enrollment: 804 (actual)

## Conditions studied

- Infection

## Interventions

- **DRUG:** Moxifloxacin (Avelox, BAY12-8039)
- **DRUG:** Ertapenem intravenous

## Key facts

- **NCT ID:** NCT00492726
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-07
- **Primary completion:** 2009-02
- **Final completion:** 2009-02
- **Target enrollment:** 804 (ACTUAL)
- **Last updated:** 2014-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00492726

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00492726, "Therapy of Complicated Intra-Abdominal Infections With Moxifloxacin or Ertapenem". Retrieved via AI Analytics 2026-08-22 from https://api.ai-analytics.org/clinical/NCT00492726. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*